INNOVATING IN ECONOMIC EVALUATION TO GENERATE EFFICIENCY AND SUSTAINABILITY

The value of health research

Committed to the sustainable development of the healthcare system, we set the foundations for the future by making decisions in the present.
For us, flexibility is strategic.

Weber
Weber presentation

Featured posts

Cost-Per-Responder Analysis of Bimekizumab (IL-17A/F inhibitor) against IL-17A and IL-12/23 Targeted Therapies for Psoriatic Arthritis in Spain, based on Matching-Adjusted Indirect Comparisons (MAIC)

Cost-per-Responder Analysis of Bimekizumab (IL-17A/F Inhibitor) Against IL-23 Targeted Therapies for Psoriatic Arthritis in Spain, Based on Matching-Adjusted Indirect Comparisons (MAIC)

Recommendations for effective patient involvement in the assessment of medical devices

Escriba su búsqueda